Rules and Tools in the Battle Against Superbugs - A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development

Forthcoming in Infectious Diseases in the New Millennium: Legal and Ethical Challenges, Mark Eccleston-Turner (ed) (Springer, June, 2020).

University of Copenhagen Faculty of Law Research Paper No. 2018-58

23 Pages Posted: 2 May 2018 Last revised: 17 Mar 2020

See all articles by Timo Minssen

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Ana Nordberg

Faculty of Law, Lund University, Sweden

Date Written: January 8, 2018

Abstract

The lack of treatments during the recent Ebola and Zika outbreaks dramatically exposed the vulnerability of the global health system and the dire consequences thereof. But even where therapies against infectious diseases had been available, an additional threat has gained world-wide attention: antimicrobial resistance (AMR). A growing number of microbial organisms are becoming resistant to available drugs with increasingly diverse risks for a rapid global spreading of infections. Unfortunately, the traditional intellectual property (IP) based innovation system and regulatory frameworks do not provide sufficient incentives to invest in the development of new antimicrobials. Hence, there are few new treatments in the pipeline to replace a growing number of ineffective drugs or problematic drug combinations. Repairing these broken economic incentives, improving access to and sustaining the effectiveness of antimicrobials is among the most important challenges in the health and life sciences. In this paper we emphasize that this goal can only be achieved through integrated strategies and a better global coordination of interdisciplinary multi-sector responses.

Keywords: Sustainable Incentives, Regulation, IPRs, Antimicrobials, Antibiotics, AM Resistance

Suggested Citation

Minssen, Timo and Nordberg, Ana, Rules and Tools in the Battle Against Superbugs - A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development (January 8, 2018). Forthcoming in Infectious Diseases in the New Millennium: Legal and Ethical Challenges, Mark Eccleston-Turner (ed) (Springer, June, 2020).; University of Copenhagen Faculty of Law Research Paper No. 2018-58. Available at SSRN: https://ssrn.com/abstract=3170921

Timo Minssen (Contact Author)

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law ( email )

Karen Blixens Plads 16
Copenhagen, 2300
Denmark
+46 708 607517 (Phone)

HOME PAGE: http://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631

Ana Nordberg

Faculty of Law, Lund University, Sweden ( email )

Lilla Gråbrödersgatan 4
Lund, 222 22
Sweden
+46462221054 (Phone)

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
56
Abstract Views
408
rank
394,171
PlumX Metrics